Franklin Resources’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$156M Sell
470,390
-317,233
-40% -$108M 0.04% 347
2025
Q4
$313M Buy
787,623
+73,611
+10% +$32.6M 0.08% 228
2025
Q3
$326M Buy
714,012
+112,681
+19% +$45.9M 0.08% 228
2025
Q2
$196M Buy
601,331
+143,017
+31% +$39.6M 0.05% 316
2025
Q1
$124M Buy
458,314
+44,175
+11% +$11.4M 0.04% 391
2024
Q4
$97.5M Buy
414,139
+31,166
+8% +$8.2M 0.03% 432
2024
Q3
$109M Buy
382,973
+93,647
+32% +$24.4M 0.03% 411
2024
Q2
$70.3M Buy
289,326
+51,802
+22% +$8.18M 0.02% 464
2024
Q1
$35.5M Buy
237,524
+86,596
+57% +$14.4M 0.01% 688
2023
Q4
$28.9M Buy
150,928
+634
+0.4% +$108K 0.01% 661
2023
Q3
$26.6M Sell
150,294
-76
-0.1% -$14.5K 0.01% 663
2023
Q2
$28.6M Sell
150,370
-10,425
-6% -$2.07M 0.01% 684
2023
Q1
$32.2M Sell
160,795
-50
-0% -$10.5K 0.02% 646
2022
Q4
$38.2M Buy
160,845
+1,550
+1% +$331K 0.02% 599
2022
Q3
$31.9M Buy
159,295
+3,185
+2% +$608K 0.02% 649
2022
Q2
$22.8M Sell
156,110
-35,559
-19% -$5.04M 0.01% 761
2022
Q1
$31.3M Sell
191,669
-18,638
-9% -$2.84M 0.01% 740
2021
Q4
$35.7M Buy
210,307
+60,652
+41% +$11.3M 0.01% 736
2021
Q3
$28.3M Buy
149,655
+146,050
+4,051% +$27.4M 0.01% 810
2021
Q2
$611K Buy
3,605
+515
+17% +$75.4K ﹤0.01% 1571
2021
Q1
$436K Sell
3,090
-490
-14% -$73.7K ﹤0.01% 1631
2020
Q4
$466K Sell
3,580
-121,685
-97% -$16.2M ﹤0.01% 1566
2020
Q3
$18.2M Buy
125,265
+1,241
+1% +$176K 0.01% 789
2020
Q2
$19.6M Sell
124,024
-414
-0.3% -$55.8K 0.01% 742
2020
Q1
$13.5M Sell
124,438
-2,098
-2% -$242K 0.01% 753
2019
Q4
$14.6M Sell
126,536
-72,646
-36% -$7.24M 0.01% 827
2019
Q3
$16M Sell
199,182
-35
-0% -$2.77K 0.01% 788
2019
Q2
$14.5M Sell
199,217
-126
-0.1% -$9.67K 0.01% 821
2019
Q1
$18.6M Buy
+199,343
New +$16.7M 0.01% 764
2018
Q3
Sell
-78,900
Closed -$7.77M 1514
2018
Q2
$7.77M Sell
78,900
-46,500
-37% -$4.61M ﹤0.01% 967
2018
Q1
$14.9M Buy
125,400
+75,000
+149% +$9.67M 0.01% 847
2017
Q4
$6.4M Buy
50,400
+30,680
+156% +$3.86M ﹤0.01% 1028
2017
Q3
$2.32M Buy
+19,720
New +$1.68M ﹤0.01% 1205
2017
Q2
Sell
-508,317
Closed -$26.1M 1499
2017
Q1
$26.1M Sell
508,317
-12,100
-2% -$559K 0.01% 719
2016
Q4
$19.5M Sell
520,417
-193,583
-27% -$8.11M 0.01% 798
2016
Q3
$48.4M Buy
714,000
+122,000
+21% +$8.61M 0.03% 540
2016
Q2
$32.9M Sell
592,000
-351,723
-37% -$22.2M 0.02% 658
2016
Q1
$59.2M Sell
943,723
-24,102
-2% -$1.6M 0.03% 491
2015
Q4
$91.1M Buy
967,825
+29,200
+3% +$2.71M 0.05% 383
2015
Q3
$75.4M Sell
938,625
-71,372
-7% -$7.93M 0.04% 425
2015
Q2
$121M Sell
1,009,997
-116,048
-10% -$13.9M 0.06% 342
2015
Q1
$118M Sell
1,126,045
-1,012,441
-47% -$103M 0.05% 350
2014
Q4
$207M Sell
2,138,486
-123,391
-5% -$11.4M 0.09% 225
2014
Q3
$177M Sell
2,261,877
-277,324
-11% -$17.9M 0.08% 249
2014
Q2
$160M Sell
2,539,201
-60,195
-2% -$3.58M 0.07% 277
2014
Q1
$175M Buy
2,599,396
+455,286
+21% +$35.2M 0.08% 256
2013
Q4
$138M Buy
2,144,110
+100,470
+5% +$5.99M 0.07% 300
2013
Q3
$131M Buy
2,043,640
+1,759,640
+620% +$87.7M 0.07% 285
2013
Q2
$8.81M Buy
+284,000
New +$7.56M 0.01% 973

Other funds holding ALNY